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Ageing, trauma and neurodegenerative diseases lead to 
cognitive, behavioural and sensorimotor deficits that 
affect the quality of life of millions of people worldwide. 
Implantable neuroprostheses provide solutions to alle-
viate many of the symptoms associated with these con-
ditions. For example, cochlear implants restore hearing 
in people suffering from profound hearing loss; deep 
brain stimulation alleviates Parkinsonian symptoms; 
spinal cord stimulators help manage neuropathic pain; 
and vagal nerve neuromodulation mitigates depres-
sion. Considering the number of patients who could 
benefit from these technologies, their dissemination 
remains limited and their potential remains compara-
tively underexploited. For example, paralysed individ-
uals have been able to control a sophisticated robotic 
arm or their own forearm muscles using brain signals 
only1,2. However, the recorded neural signals extinguish 
rapidly3, which currently restricts the clinical potential 
of these implantable brain–machine interfaces4.
Historically, the biocompatibility of a neural implant 
has been mostly quantified in terms of chemical and 
electrochemical stability, and toxicity. However, tissue– 
implant interactions are triggered by very different phe-
nomena, such as insertion trauma, neuroglial activation, 
cell migration and blood–brain barrier breakdown, that 
occur in concert and at multiple time points. In this 
Review, we explore one of these critical interactions 
that impedes the deployment of existing and contem-
plated implantable neuroprostheses: the physical and 
mechanical mismatch between man-made implants 
and the targeted neural tissues. Cells and neural tissues 
are several orders of magnitude softer than the materials 
used in neural implants. Cells respond to the mechan-
ical properties of the surfaces they are in contact with. 
In vitro, environments with adjustable stiffness show that 
cells alter their motility, shape, differentiation outcome, 
activation and general function on the basis of the com-
pliance and topography of their surroundings. In vivo, 
the soft neural tissues display viscoelastic properties that 
are often anisotropic, withstand uninterrupted motion 
due to blood flow, respiratory pressure and natural body 
movements, and undergo changes in volume through-
out life. By contrast, most neural implants are rigid and 
static. For example, clinical implants are often prepared 
with platinum–iridium electrodes and stainless-steel 
wires embedded in silicone to form flexible, millimetre- 
thick electrode paddles5–7. They may be machined with 
a built-in curvature to provide consistent electrode con-
tact with the neural tissue. Such design is suitable for 
neurostimulation devices that require large electrode 
contacts over the surface of the brain or spinal cord. 
However, this type of technology fails to provide the 
resolution and stability that is necessary for long-term 
recordings of neural signals owing to the substantial 
distance between the electrode and targeted neurons. 
Implantable electrodes prepared in both academic 
environ ments and commercial research and develop-
ment are prepared from a broader palette of materials 
borrowed from microelectronics, and biomedical and 
regenerative technologies. In the past decade, advances 
in soft bioelectronics — mechanically compliant elec-
tronics customized to interface biological tissues — have 
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Abstract | Implantable neuroprostheses are engineered systems designed to restore or 
substitute function for individuals with neurological deficits or disabilities. These systems 
involve at least one uni- or bidirectional interface between a living neural tissue and a synthetic 
structure, through which information in the form of electrons, ions or photons flows. Despite a 
few notable exceptions, the clinical dissemination of implantable neuroprostheses remains 
limited, because many implants display inconsistent long-term stability and performance, and 
are ultimately rejected by the body. Intensive research is currently being conducted to untangle 
the complex interplay of failure mechanisms. In this Review, we emphasize the importance of 
minimizing the physical and mechanical mismatch between neural tissues and implantable 
interfaces. We explore possible materials solutions to design and manufacture neurointegrated 
prostheses, and outline their immense therapeutic potential.
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enabled novel strategies to remedy the issues of physi-
cal and mechanical mismatch and to restart the design 
process of implantable neuroprostheses8–10.
Here, we review recent strategies to design, manu-
facture and implement soft implantable neuroprostheses 
with improved biointegration and enhanced functional-
ities. We describe the shape, surface topology and bio-
mechanics of neural tissues across mammalian species, 
and translate these physiological properties into design 
guidelines to construct physically matched synthetic 
implants. We provide examples of recent implantable 
neuroprotheses that have achieved superior neuro-
integration through designs, materials or technologies 
that obeyed at least one aspect of these guidelines. We 
conclude in discussing the enticing potential of soft 
implantable neuroprostheses to replace and restore neural 
functions after trauma and neurological disorders.
Understanding neural materials
Macroscopic and morphological considerations
The mammalian central nervous system (CNS) is argu-
ably the most complex biological organ. The CNS is 
composed of the brain and spinal cord, which send and 
receive signals to and from the rest of the body via the 
peripheral nervous system (PNS). Despite its peripheral 
location, the retina is also part of the CNS. The size and 
topography of the brain display remarkable differences 
across mammalian species (FIG. 1a). The adult human 
brain weighs approximately 1.5 kg (REF. 11) and the surface 
of the cerebral cortex is greater than 2,500 cm2. The brains 
of the main animal models used in neuroprosthetic 
research pale in comparison. For example, the weight of 
the brain and surface area of the cerebral cortex range 
from 1.8 g and 6 cm2 for the adult rat12 to 90 g and 110 cm2 
for the rhesus monkey13. The topologies of the brain also 
differ widely: small mammals have smooth brain sur-
faces, whereas the brains of primates (including humans) 
display complex external topographies and patterns of 
convolution that result from gyrification of the cortical 
surface14 (FIG. 1a). Gyrification refers to the cortical fold-
ing that gives the brain its wrinkle-like appearance with 
ridges (gyri) and grooves (sulci)15. The cerebral cortex of 
humans — the outer, 2–3- mm-thick layer of grey mat-
ter over the brain hemispheres — is a highly convoluted 
structure, with more than half of its actual surface area 
hidden from the apparent, directly accessible outer brain 
surface. Typical sulci radii and gyri depths in the cortex 
of primates13 are in the range of 1–5 mm.
In the CNS, the cerebral and spinal tissues are pro-
tected by a multi-layered structure formed of meninges 
(that is, membranes including the pia mater, arachnoid 
mater and dura mater), bone, connective tissue and 
skin (FIG. 1b,c). In the PNS, longitudinal axon bundles 
are grouped in fascicles protected by the perineurium, 
which in turn may be bundled together with blood 
supply and fatty tissue within another sheath, the 
epineurium (FIG. 1d). Each of these membranes has a 
key mechanical role in protecting the delicate neural 
tissues and mitigating their dynamic response, not only 
to physiological movement and pressure changes in the 
cerebrospinal fluid, but also to injury.
Neural tissues withstand constant mechanical 
activity. The brain is a pulsatile organ submerged in 
cerebro spinal fluid and regulated by cardiac cycles and 
respiration. Adequate blood flow to the brain is cru-
cial for maintaining normal brain function. Because 
the brain is enclosed in the rigid skull, pressure and 
flow pulsations are transferred to the soft brain tissue 
(resulting in local motion on a micrometre scale), arte-
rial and venous network, and cerebrospinal fluid16. In 
freely behaving mammals, ventroflexion (that is, bend-
ing forward) causes tensile elongation of the spinal cord 
tissue accompanied with Poisson compression, whereas 
extension (that is, bending backwards) causes wrinkling 
of soft tissues inside the spinal canal. In humans, both 
the spinal cord and its meningeal protective membranes 
can experience as much as 10–20% tensile strain and 
displacement (relative to the spinal canal) during nor-
mal postural movements. This motion corresponds to 
displacements on the order of centimetres17. The defor-
mations relative to the spinal cord in animal models, 
such as rodents or non-human primates, are likely to 
be even larger.
The mechanical properties of the dura mater and 
the nerve epineurium and perineurium are especially 
relevant for neural implants, because most interfaces lie 
immediately above or below this protective membrane 
or must pierce through it in order to access the neural 
tissue. The dura mater consists of collagen fibres that 
are interdispersed with fibroblasts and elastin and is 
traversed by a network of blood vessels. In humans, its 
thickness varies from 0.3 to 0.8 mm, depending on the 
age of the individual18,19. Both cranial and spinal dura 
maters exhibit hyperelastic and viscoelastic stress–strain 
behaviour, typical of collagenous tissues, with an elastic 
modulus of 0.5–1.2 MPa (REF. 20). Their toughness also 
prevents the insertion of brittle electrodes through the 
dura mater without performing a surgical incision of the 
meninges and/or the use of guide tubes or cannulas.
Peripheral nerves are anisotropic structures that 
spread throughout the body. They vary significantly 
in diameter; for example, the small visceral nerves are 
about 100 times smaller than the sciatic nerve, which 
reaches up to 2 cm in diameter in humans. Nerve epineu-
rium and perineurium are formed of bundles of collagen 
fibres and elastin21. When tension is applied to a nerve, 
its initial undulated resting shape accommodates some 
elongation without generating appreciable stress along 
the fascicles and axons. The elasticity of the connective 
tissue surrounding a nerve helps preserve the integrity 
of the axon. As the tensile loading increases, the nerve 
displays quasi-elastic stress–strain behaviour until rup-
ture of the perineurial sheath, which occurs with a frac-
ture strain of ~25% and an ultimate stress of ~10 MPa. 
Nerve fibres start to rupture in the endoneurium sheath 
at lower strains21.
Cellular considerations
The brain and spinal cord host different kinds of neu-
rons and several types of glial cells, which interact in 
many intricate and mutually supporting ways to enable 
the overall functional performance of the neural tissue. 
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The stereotypic nerve cell presents a cell body (soma) 
and between 1 and about 1,000 dendrites, which receive 
signals via synapses from other nerve cells. After integra-
tion and processing of this external information, action 
potentials propagate towards other cells via a single, long 
process called the axon. The axon is a few micrometres 
thick, but can reach up to a metre in length. The network 
of neuronal processes conveys a considerable amount of 
mechanical connectivity throughout the tissue. The func-
tion of the various glial cell types is to support and mod-
ulate the performance of the neurons. Oligodendrocytes 
(similar to Schwann cells in the PNS) produce thin and 
wide insulating myelin sheaths wrapped around each 
axon. These cells primarily support the transport of 
information along the axon, but also offer additional 
mechanical connectivity to the tissue. Astrocytes provide 
general biochemical support to other cells and modulate 
the information processing at synapses. They also con-
tribute to the repair of tissue after injury and the forma-
tion of scars that protect the neural environment from the 
rest of the body. Microglia are the resident immune cells 
of the CNS, which also initiate and mediate the foreign 
body reaction (FBR) against foreign material, such as 
implants, introduced into the CNS22.
The material properties of these cellular tissue constit-
uents contribute to the stiffness of the entire tissue. Their 
intrinsic properties have been investigated23,24 after iso-
lation from the tissue. Neurons, isolated from neo natal 
rat cortex, guinea-pig hippocampus and retina, have 
been probed with atomic force microscope (AFM)-based 
nano-indentation, which revealed rate-dependent, non-
linear viscoelastic behaviour with shear moduli between 
a few tens to a few hundred pascals25–27. In these studies, it 
was found that under lateral compression, neuronal and 
glial processes were softer than their somata26. However, 
a more recent study using magnetic tweezers for local 
rheological measurements revealed that the soma is 
softer and more solid-like compared with the stiff and 
viscous-like neurites. The authors concluded that axons 
are probably more sensitive to mechanical damage than 
the soma28. However, the main load-bearing direction of 
neural processes is actually oriented along their length, in 
which elastic spring constants of a few hundred mN m−1, 
viscoelastic relaxation and also active contraction have 
been observed29–34. It is noteworthy that processes of neu-
rons in the CNS display lower spring constants than those 
of neurons in the PNS8,22–24. In contrast to many other 
cell types, glial cells are roughly as compliant as neurons 
with Young’s moduli on the order of ten to a few hundred 
pascals26,35,36. Relevant in the context of the FBR against 
implants is that cell stiffness can change when cells are 
activated. For example, acutely isolated Müller glial cells 
from an ischemic retina are stiffer than the cells from a 
healthy retina. This increased stiffness is attributable to 
an increase in the density of intermediate filaments such 
as glial fibrillary acidic protein (GFAP) and vimentin36. By 
contrast, cultured primary astrocytes soften considerably 
following either interferon‑β (IFNβ) stimulation37 or a 
stretch-induced upregulation of GFAP38. To our knowl-
edge, no information on microglial stiffness has been 
reported so far, which is probably because of the phago-
cytic activity of these cells when they are in contact with 
a measurement probe.
Tissue considerations
The extracellular matrix (ECM) is embedded in the inter-
stitial space between the cell bodies and their processes. 
The ECM consists of fibrous proteins, proteoglycans and 
glycosaminoglycans, such as laminin and hyaluronan. In 
the CNS, these elements form a dense mesh39–42 with a 
striking scarcity of collagen, which is the dominant ECM 
component elsewhere in the body43. In the adult human 
CNS, the total volume fraction of the ECM is about 20%44. 
For a recent review of the regional distribution of these 
ECM components and the corresponding cell adhesion 
molecules in the CNS, see REF. 45. In addition to their direct 
biological function, the ECM molecules maintain adhe-
sion between cells and thus provide additional mechanical 
resistance to the deformation of the entire tissue.
How these components — cells and the ECM — 
contribute to the overall mechanical properties of the 
CNS tissue is still poorly understood. Their relative 
importance is probably inverted compared to that of 
Figure 1 | Structure and anatomy of the nervous system. a | Schematic illustrations 
of the lateral and coronal views of the brain across mammalian species. Illustrations of 
the anatomy of the human brain (part b), the spinal cord (part c) and a peripheral nerve 
(part d) are also shown.
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most other soft tissue in the body, for which the stiff-
ness is largely dominated by a polymer matrix formed 
of collagen with the interstitial cells having less impor-
tance. Consequently, both collagen gels reconstituted 
in vitro and most body tissues display strain stiffening 
and compressive softening. Brain (and fat) tissue exhib-
its the opposite mechanical behaviour: it stiffens under 
compression but softens with strain46. This behaviour is 
consistent with the picture of the brain as largely a dense 
colloidal system (in which the cell bodies are the colloids) 
connected by an adhesive mesh of ECM, direct cell–cell 
contacts and connections via cell processes (for exam-
ple, dendrite, axon and glial processes). The overall CNS 
stiffness is comparable to that of individual cells and, for 
example, in the brainstem, axons have been shown to be 
stiffer than the surrounding ECM47. Further, as previ-
ously mentioned, collagen is absent from the ECM of the 
brain, which only takes about 20% of the volume and thus 
is unlikely to have a large load-bearing role. Both neural 
cells and ECM are nonlinear mechanical entities that can 
alter their properties under isotropic pressure and aniso-
tropic tension or compression48. In addition, pH and ions 
in the interstitial liquid, together with their interplay 
with the highly charged and sulfated ECM components, 
contribute osmotic and additional charge effects49.
Despite the current lack of a comprehensive, bottom- 
up model of the mechanical properties of CNS tissue, 
there is no scarcity of experimental reports on the 
mechanical properties of brain, spinal cord and retina, 
both in vivo and in vitro, and at spatial scales from organ 
to cell. Since the first measurements in the 1960s50,51, 
there are now several excellent reviews covering the wide 
spectrum of work conducted on this topic23,48,49,52. For the 
bulk brain, typical elastic moduli reported range from a 
few 100 Pa to about 10 kPa in oscillatory shear rheolog-
ical measurements in vitro, depending on strain, shear 
rate, preconditioning and several other factors48. This 
also holds for the spinal cord48,53 and retina54.
On a smaller scale, depending on the region of the 
CNS, different types, spatial orientations and relative 
numbers of neurons, glial cells and their processes, as 
well as different amounts of ECM, contribute to the 
mechanical properties measured53,55–59. For example, 
grey matter regions in the cerebellum, consisting mainly 
of cell bodies, tend to be stiffer (Young’s modulus meas-
ured with AFM, E ≈ 450 Pa) than white matter regions 
(E ≈ 300 Pa), which essentially contain many axonal 
tracts60. A similar result has been reported for the rat 
spinal cord measured with AFM, further demonstrating 
the greater anisotropy of white matter53. Even on a larger 
scale, this result seems to hold61. The difference between 
white and grey matter might stem from the lower cell 
density in the former53, which is structurally dependent 
on the oligodendrocyte connectivity, because demyeli-
nation in the rat spinal cord leads to lower stiffness and 
tensile stress62. Lower stiffness has also been reported 
for demyelinated regions in the murine brain paren-
chyma measured with magnetic resonance elastography 
(MRE)63. Although this seems to form a clear picture, it 
should be noted that there are also reports of white matter 
being 40% stiffer, and more viscous, than grey matter55. 
Age can also have a role, with older brains tending to be 
stiffer64. By contrast, MRE shows fluidization with age 
(and that female brains are more elastic than male 
brains)65. Such discrepancies are not uncommon in this 
field and are widely discussed22,47,51,65,66. They could ema-
nate from different preparative procedures of the tissue, 
time and length scales, as well as modes of deformation, 
and the change of properties between in vivo and in vitro 
measurements, among other possible factors. Improved 
microscopic models of brain tissue might help to resolve 
these differences in the future49,66.
Important features for neural implant design
Given the uncertainties discussed in the previous subsec-
tions, what are the reliable features and what do we need to 
consider in the design of neural implants? One important 
parameter is the compliance of the neural tissue, quan-
tified by its Young’s modulus and reported in the range 
of 100 Pa to 10 kPa for CNS tissue. In contrast to other 
biological tissues, the high compliance of the CNS tissue 
is independent of species, age and regions within the CNS. 
Another important feature to consider when evaluating 
materials properties for the design of future implants is 
the size. Indeed, tissue stiffness values strongly depend 
on the probing technique, associated probe format and 
rate at which the tissue is strained. For example, the low-
est values of about 100 Pa obtained by AFM53,57,60,64 for the 
CNS modulus are probably due to tissue constituents, and 
importantly water, being able to accommodate and flow 
around the micrometre-sized, indenting probe. On scales 
much larger than that of the tissue constituents, or in ten-
sile probing, the incompressibility of water will probably 
contribute a much greater resistance to motion and thus 
yield a higher elastic modulus67. Consequently, it could be 
possible for large implants to be kept stiffer (on the order 
of 10 kPa) than implants with fine features on a cellular 
scale, such as thin meshes or micrometre-scale wires.
A third parameter to consider is the mechanical con-
trast between the pulsating neural tissue and the static 
implant. The recurrent motion of the surrounding tissue 
with respect to implants will cause different kinds of 
damage, depending on the physical properties of the 
implant68. The insertion of the implant into the brain 
also alters the mechanical properties of the surrounding 
tissue itself. After the implantation of microelectrodes, 
brain tissue exhibits appreciable stiffening during the first 
four weeks after implementation owing to the formation 
of a stiff matrix surrounding the implant. This matrix 
gradually softens and the stiffness eventually returns to 
its original value (that is, before implantation)68. A more 
extreme example is the effect of a lesion on neural tissue. 
For example, the hemisection of a rat spinal cord leads to 
a decrease of the elastic modulus but an increase of the 
viscosity, measured by micro-indentation 2 and 8 weeks 
after injury69.
The development of most neural implants is con-
ducted in mammalian animal models. Therefore, the 
similarities and differences in the mechanics, morphol-
ogy and size of relevant tissues between the most com-
mon animal models and humans must be taken into 
consideration. In a study70 published in 1970, it was 
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Cortical bone: ~10 GPa
Dura mater: ~1 MPa
Spinal cord and brain:
100 Pa to 10 kPa
Skin: 10–100 kPa
Tungsten microwire array: 
~200 GPa
Thin polyimide array:
~5 GPa
Electronic dura: 
~1 MPa
Silicon Utah array:
~150 GPa
100 GPaE 1 GPa 1 MPa 1 kPa
Biological tissue
Neural implants
found that human tissue is slightly softer than that of 
the rhesus monkey. However, the limited and sporadic 
availability of CNS tissue has restricted the evaluation of 
tissue mechanics ex vivo in humans. Consequently, no 
systematic comparison between human and other spe-
cies is available. If the mechanical properties can safely 
be assumed to be very similar, one aspect that does dif-
fer considerably is the relevant sizes involved. Whereas 
a mouse brain has a diameter of about 1 cm, a human 
brain is about 15 times larger (FIG. 1a). Other CNS features 
and macroscopic curvatures exhibit similar differences in 
scale among species. These differences pose design con-
siderations in terms of the bending stiffness (thickness) 
of implants when scaling up from small animal models to 
implants for use in humans. This is especially true when 
implant conformity to the increasingly undulated brain 
surfaces from mouse to primate brains is important.
We are still far away from a having a thorough under-
standing of the complex and intricate mechanical proper-
ties of CNS tissue, which itself is an interesting frontier of 
materials research. However, we probably know enough 
to start tailoring implants that match the mechanics of the 
brain. In the following section, we highlight recent techno-
logical efforts geared towards implementing mechanical 
compliance in synthetic materials and implants.
The soft neurotechnology toolbox
Today, there is no worldwide consensus on the most 
appropriate implantable materials for neural interfaces. 
Platinum–iridium, titanium, stainless steel and sili-
cones are widely used in clinical devices following strin-
gent and local standards regulated, for example, by the 
International Organization for Standardization (ISO) in 
Europe, the US Food and Drug Administration (FDA) 
and the Ministry of Health, Labour and Welfare (MHLW) 
in Japan. It is also important to consider that an approved 
material in its bulk form may no longer be biocompat-
ible once transformed, processed and/or used in a neu-
ral implant. New materials and assembly techniques are 
not systematically discarded because of biosafety or bio-
compatibility standards, but their validation and approval 
may be long and laborious.
Considering electrode–tissue mechanical interac-
tions, nearly all implantable electrodes, whether clin-
ically approved or under development, are stiff with a 
mismatch in elastic moduli of several orders of magni-
tude compared with the targeted neural tissue (FIG. 2). 
Their insertion into living neural tissues triggers bidi-
rectional interactions (that is, both implant-to-tissue 
and tissue-to-implant responses). Man-made implants 
induce insertion-related trauma to the host biological 
tissues, acute and then chronic inflammation, gliosis 
and disruption of the blood–brain barrier71. Conversely, 
the active and reactive biological medium affects the 
synthetic devices. These alterations include structural 
degradation5, material corrosion, insulating material fail-
ure4 and electrode impedance fluctuation6 over periods of 
weeks to months. These changes compromise the stability 
and capability of recording or stimulating neural signals. 
Recent efforts in smart materials and soft bio electronics 
aim at tackling the multiscale, multifunction mismatches 
between neural tissues and man-made implants. The 
majority of these approaches involve the design of flex-
ible mechanical structures7–9, the engineering of elastic-
ity in a stiff and rigid material7–9 and the integration of 
softer materials into implants20,72. Two main objectives 
are being jointly pursued with the ‘soft neurotechnology’ 
toolbox: minimizing the long-term FBR and implement-
ing multiple recording and neuromodulation modalities 
in mechanically compliant structures.
Reduced foreign body reaction
The surgical insertion of a synthetic device in the vicinity 
of or into a neural tissue triggers an immediate FBR that 
continues throughout the in vivo lifetime of the neural 
implant. This acute inflammation will turn into a chronic 
neuroinflammatory response characterized by a com-
plex interplay of molecular and cellular components. 
Figure 2 | Mechanical mismatch between the nervous tissues and man-made implantable electrodes. Soft neur l 
tissues are wrapped in elastic dura mater and encased in hard bone sheath. Neural electrodes are traditionally made 
of stiff microelectronic materials (for example, metals such as tungsten microwires, inorganic semiconductors such as 
Silicon Utah arrays123 and plastics such as polyimide arrays124) and have only recently matched the dura mater 
mechanical characteristics20. E, Young’s modulus. Image of the tungsten microwire array (5 × 5 mm2) is courtesy of 
Tucker-Davis Technologies. Image of the silicon Utah array (2 × 2 mm2) is reproduced with permission from REF. 123, 
Elsevier. Image of the polyimide array is reproduced with permission from REF. 124, Institute of Physics. Image of the 
electronic dura (implant width: 5mm) is reproduced with permission from REF. 20, AAAS.
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Persistent inflammatory stimuli exacerbate the chronic 
inflammation22.
Mechanical stiffness of conformal surface implants. 
The physical and material properties of the implant, as 
well as the site of implantation, affect the intensity and 
duration of inflammatory and healing processes. Static 
and rigid implants fail to accompany the natural micro- 
and/or macroscopic motion of the neural tissues. Several 
groups have now demonstrated that the mechanical dif-
ferences between neural tissues and implant materials 
induce adverse strain fields in the immediate vicinity of 
the device, which may lead to irreversible tissue damage 
and electrode failure4,71,73,74.
Surface implants should conform as much as possible 
to the convoluted surface of the brain (FIG. 3), spinal 
cord or peripheral nerves (FIG. 4). Implant (macroscopic) 
compliance may be achieved through the use of ultrathin 
materials. The flexural stiffness, D, of a material is 
defined in equation 1: the thinner the material, the more 
bendable it is75.
D = 12(1 – v2)
Eh3
  
(1)
where E is the elastic modulus, h is the thickness of 
the material and ν is Poisson’s ratio. For example, the 
use of ultrathin and flexible electrodes combined with 
micrometre-thick silicon transistor membranes has 
enabled recordings of electrocorticograms (EcoG) from 
inaccessible cortical areas such as the interhemispheric 
fissure76,77.
To accommodate the dynamics of the neural tissue, the 
tensile stiffness of the implant is another crucial design 
parameter. The tensile stiffness determines the ability of 
the implant to reversibly expand and relax with the under-
lying tissue. Patterning extremely thin (<10 μm) and stiff 
films into web-like systems improves the mechanical 
coupling between the implant and the underlying mov-
ing tissue. On mechanical loading, the mesh develops into 
3D out-of-plane structures with engineered compliance. 
These 3D topologies have been exploited to fabricate 
stretchable metallic conductors78 that conform to the 
curved surface of the skin79 and biological organs9,80. A 
transient packaging material (for example, silk) is usually 
added to coat the delicate open-mesh surface and to ease 
handling and surgical insertion76. However, the dimen-
sions of the mesh ligaments should be carefully controlled. 
Indeed, even in a thin and narrow rectangular format, 
the stiff and non-elastic mat erial may severely limit the 
motion of the underlying neural tissue, or debond and 
slide against it, which is likely to induce and exacerbate 
damage and neuroinflammation.
Figure 3 | Compliant and multimodal neural interfaces for the brain. Examples of implantable systems micro- and 
nanomachined to match the brain morphology and communicate efficiently using electrons, photons and chemical 
compounds. The recording and stimulation modalities are listed for each type of implant. References of the reported 
devices are: stentrode99; subdural arrays20, which include meshed98 and bioresorbable arrays83; penetrating  array117; 
multimodal fibre94,95,124; conformal array124; and injectable mesh97.
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An alternative approach involves the manufacturing 
of the implant with elastic materials that render it soft 
and stretchable. When designed in a solid membrane 
format, this type of soft implant presents several advan-
tages over thin films. First, the membrane is robust, 
which facilitates the handling of the implant and its 
surgical insertion into intricate regions of the CNS. For 
example, these membranes have been implanted chron-
ically below the dura mater of the brain and spinal cord 
in rats. Second, these soft implants do not trigger the 
FBR. Indeed, a soft implant inserted subdurally prepared 
as a macroscopic membrane of elastomers with tensile 
mechanics matching that of dura mater20,81 proved 
nearly imperceptible to the underlying tissue even after 
weeks of implantation (FIG. 5a,b). This immediate and 
long-lasting biointegration is especially promising for 
ECoG arrays, which are typically used to monitor neural 
activity from the cortical surface.
Bioresorbable implants, prepared with ultrathin 
implantable electrode technology, also promise improved 
biointegration in acute and short-term transient neural 
interfaces. The nanometre-thick materials embedded 
in thin resorbable substrates yield devices with levels 
of mechanical flexibility necessary for conformal con-
tact and stable interfaces with neural tissues for a preset 
duration82,83.
Mechanical coupling of penetrating electrodes. The phys-
ical coupling between penetrating electrodes and neural 
tissues is even more complex given the trauma, local 
inflammation and astroglial scarring around the implant. 
Combinatorial strategies ranging from molecular bio-
logy to engineering are needed to design and implement 
long-term ‘stealth’ and functional implants. Here, we focus 
on the importance of the mechanical coupling between 
the implant and the tissue. A more exhaustive review on 
the various factors at work may be found in REF. 7.
Macroscopically, the implant should be mechanically 
decoupled from (but electrically communicating with) 
its anchoring point, which is usually in the surround-
ing bone via a flexible electronic cable. This decoupling 
allows the probe to move with the neural tissue1,20. The 
mechanical response of the neural tissue to the insertion 
of a penetrating implant is influenced by the geometry of 
the probe and the speed at which the probe is inserted. 
Rapid insertion of sharp implants84 (>1 mm s−1) made of 
stiff materials, such as silicon, is often favoured, because 
clean transection of fibres and cell membranes results in 
less distortion or tearing of neurons and vascular dam-
age85. A low insertion speed (<200 μm s−1) may, however, 
better account for the viscoelastic response of the brain 
and provide time for displaced capillaries and fibres to 
recover without rupture85.
Figure 4 | Compliant and multimodal interfaces for the spinal cord and the peripheral nerves. Examples of 
implantable systems that have been micromachined to conform to the delicate surface of spinal tissues but minimally 
penetrate the tissues include multimodal fibres96, epidural arrays119, subdural arrays20 and organic bioelectronics113 
(part a). Implants that mimic the macroscopic anatomy of peripheral nerves include cuff implants125,126, transversal 
arrays127,128 and regenerative arrays129 (part b).
R E V I E W S
NATURE REVIEWS | MATERIALS  ADVANCE ONLINE PUBLICATION | 7
©
 
2016
 
Mac mill an
 
Publishers
 
Li mited,
 
part
 
of
 
Spri nger
 
Nature.
 
All
 
ri ghts
 
reserved. ©
 
2016
 
Mac mill an
 
Publishers
 
Li mited,
 
part
 
of
 
Spri nger
 
Nature.
 
All
 
ri ghts
 
reserved.
Nature Reviews | Materials
a   Biointegration on the spinal cord b   Inﬂuence of implants on spinal cord
Pristine Soft Stiﬀ
L2
S1
S2
T13
Im
pl
an
t
Microglia
Astrocytes
N
orm
alized cell density
0.0
0.5
1.0
Reactive astrocytes (GFAP) IgG immunoreactivityMicroglia and macrophages
1 cm
Spinal tissue
Orthotic screw
Elastomeric
substrate
L2
L4
Vertebra
Connector
G
FA
P
Ib
a1
1 mm
Stiﬀ Compliant Stiﬀ Compliant Stiﬀ Compliant
5 mm
1 mm
Dura mater
Electrode
Elastomeric 
substrate
Spinal tissue
500 μm
100 μm 100 μm 100 μm 100 μm 100 μm 100 μm
c   Foreign body reactions around stiﬀ and compliant shank implant
Inﬂammation 
zone
Neurons
Reactive
astrocytes
Stiﬀ
Microglia and 
macrophages
Activated microglia and 
macrophages Compliant
R E V I E W S
8 | ADVANCE ONLINE PUBLICATION www.nature.com/natrevmats
©
 
2016
 
Mac mill an
 
Publishers
 
Li mited,
 
part
 
of
 
Spri nger
 
Nature.
 
All
 
ri ghts
 
reserved. ©
 
2016
 
Mac mill an
 
Publishers
 
Li mited,
 
part
 
of
 
Spri nger
 
Nature.
 
All
 
ri ghts
 
reserved.
◀Buckling of the soft implant during the surgical insertion 
is an important parameter that must be accounted for. 
Intuitively, small cross-section probes made of soft mat-
erials will easily bend at the surface of the tissue. Several 
strategies have been proposed to facilitate the insertion 
of soft implants. These strategies include the use of 
insertion aides86, dissolvable, rigid carriers87, stiffening 
of the implant backbone88 and larger designs (>1-mm2 
cross-section). An interesting alternative is the imple-
mentation of mechanically adaptable materials: that is, 
engineered polymers that soften once in vivo. Such mat-
erials have been implemented in a range of biomedical 
applications and have only recently been explored for 
neural interfaces. In situ softening may be produced with 
shape-memory polymers89 or smart nanocomposites90. A 
biomimetic approach inspired by the structure of the der-
mis of the sea cucumber led to a mechanically adaptive 
material that can switch from a stiff and dry form (with 
a GPa-range Young’s modulus) to a soft matrix (with a 
MPa-range Young’s modulus) after a 10–20-minute 
insertion in a physiological environment90. The nano-
composite of a poly(vinyl acetate) matrix reinforced 
with rigid cellulose nanocrystals can also be machined 
in shank-like arrays with ~100-μm2 cross-section that 
can be inserted through the pia mater of the cortex 
of rats without assistive surgical devices91. Systematic 
evaluation of the neuroinflammation response to these 
mechanically adaptive probes during a 16-week implan-
tation demonstrated that over time, and in contrast to 
chemically matched but stiff probes (FIG. 5b), activation 
of inflammatory cells was nearly completely attenuated 
and neuronal loss around the soft implant was substan-
tially reduced92. Mechanically adaptable materials are 
also finding promising applications for peripheral nerve 
interfaces89,93.
Minimizing the electrode footprint. In both the brain94,95 
and spinal cord96, soft neurotechnology strategies also 
include fibre-like designs and injectable devices (FIGS 3,4). 
Ultrasmall carbon fibres with subcellular cross-sections 
insulated with parylene N and conducting polymer 
poly(3,4-ethylenedioxythiophene) polystyrene sul-
fonate (PEDOT:PSS)-coated tips enable chronic record-
ings of single-unit activity in rats for several weeks94. 
Multi-electrode fibres prepared by thermal drawing — 
a process borrowed from the fibre-optic industry — are a 
recent and promising design. In one study, microelec-
trodes (5 μm in diameter) clustered in a single fibre 
(125 μm in diameter) were used to monitor neural activ-
ity at the single-unit level over a period of 2 months95. 
The fibres were prepared with insulating poly(phenyl-
sulfone) or poly(etherimide) and conductive tin. In 
both examples, fibres remained intact in the brains of 
rats or mice for weeks of implantation, enabling clear 
recordings over this time range. Compared with multi- 
electrode silicon shanks, the ultra-miniaturized fibres 
triggered less glial response, blood–brain barrier breach 
and tissue encapsulation in the vicinity of the probes95.
Injecting miniaturized and ultra-flexible electronics 
into brain tissue is another approach to interface the soft 
tissues in a minimally invasive procedure with reduced 
FBR (FIG. 3). A polyimide shank-like probe with very low 
bending stiffness and a small footprint can be tempo-
rarily mounted on a releasable carrier needle, which 
detaches once injected into the soft neural tissue87. 
Another design proposes a macroporous mesh made of 
narrow SU8 epoxy branches97. The high degree of poros-
ity (~80%) of the implant together with subcellular fea-
ture sizes allow for a synthetic implant with extremely 
small bending stiffness and high malleability. The mesh 
format unfolds once in vivo into a 3D interface. Such a 
probe may be either injected through a hollow needle and 
then deployed in the liquid compartment of the brain 
(FIG. 3) (that is, the ventricles where the cerebrospinal 
fluid is produced)97 or frozen in liquid nitrogen for rapid 
insertion into the cortex98. Cortical tissues carrying the 
macroporous ultra-flexible implants for several weeks 
display high biocompatibility as neural tissue invades 
the macroporous network. This response minimizes the 
electrode–neuron distance. Combined with a mature car-
diovascular technology, the mesh design can also be used 
to form a stentrode. This novel implant is a combination 
of a stent, thin electrodes and transmitters injected into 
a vein via a catheter to travel in the brain through the 
bloodstream99.
Engineering the local mechanical microenvironment. 
Engineering of the mechanical (and surely biochemical) 
microenvironment at the surface of an implant may be 
needed to further modulate the FBR. It is increasingly 
appreciated that neurons and glial cells respond to the 
mechanical properties of their surroundings23,100: neu-
rons prefer softer regions over stiffer regions for growth 
and branching101; oligodendrocytes have an optimal 
stiffness of about 700 Pa (Young’s modulus) for growth, 
proliferation, migration and differentiation35; astrocytes 
and microglia become activated on stiff surfaces102; and 
microglia migrate to regions that are stiffer (that is, with 
a Young’s modulus >10 kPa)103. One obvious approach to 
pacify cells in contact with an implant seems to be the use 
of materials with the same bulk modulus as CNS tissue. 
Figure 5 | Mechanosensitivity and foreign body reaction in the central nervous 
system. a | Biointegration of a subdural, soft implant at the surface of the spinal cord.  
The top panel depicts a cross-section of an electronic dura inserted in the spinal 
subdural space of a rat. The bottom panel is the corresponding reconstructed 3D 
micro-computed tomography scan (5 weeks after insertion) of the electronic dura 
covering the L2 to S1 spinal segments. b | Influence of soft and stiff implants on the 
spinal cord. The top panel illustrates 3D spinal cord reconstructions, including 
enhanced views 6 weeks after implantation. The photographs on the left of the 
bottom panel are of microglia (Iba1) and astrocyte (GFAP) staining, which reflect 
neuroinflammation (scale bars: 30 μm). The heat maps on the right show the 
normalized microglia (upper row) and astrocyte (lower row) density. c | The top two 
panels are schematic representations of the foreign body response around a stiff and 
a compliant penetrating shank into the cortex. Stiff implants (for example, poly(vinyl 
acetate)-coated silicon) induce increased gliosis, blood–brain barrier permeation and 
neurodegeneration in comparison to compliant materials (for example, poly(vinyl 
acetate)/tunicate cellulose nanocrystal nanocomposites) as shown in the 
photographs below. L2, L4, lumbar spinal discs; S1, S2, sacral spinal discs; T13, 
thoracic spinal disc; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium-binding 
adaptor molecule 1; IgG, immunoglobulin G. Parts a and b are reproduced with 
permission from REF. 20, AAAS. Part c is adapted with permission from REF. 92, 
Institute of Physics.
R E V I E W S
NATURE REVIEWS | MATERIALS  ADVANCE ONLINE PUBLICATION | 9
©
 
2016
 
Mac mill an
 
Publishers
 
Li mited,
 
part
 
of
 
Spri nger
 
Nature.
 
All
 
ri ghts
 
reserved. ©
 
2016
 
Mac mill an
 
Publishers
 
Li mited,
 
part
 
of
 
Spri nger
 
Nature.
 
All
 
ri ghts
 
reserved.
▶As a proof of concept, implantation of (non-elec-
trically functional) soft hydrogel stripes (with an elas-
tic modulus of 100 Pa) caused less FBR than stripes of 
the same mat erial that were two orders of magnitude 
stiffer102 (FIG. 5c). The slowly accumulating insight into 
the molecular mechanisms of the mechano sensing23,104–106 
will allow drugable, pharmacological targets to be iden-
tified in order to better avoid FBR-causing mechanosen-
sitivity of cells in contact with an implant. Slow release 
of suitable agonists could then be built into the implant 
surface to mechanically silence the cells in contact with 
it (that is, pharmacological stealthing of the implant). 
It is noteworthy that controlled in vivo release of bio-
active agents, such as anti-inflammatory drugs107 and 
neurotrophic factors, can be integrated into conduct-
ing polymer materials108. However, the latter are prob-
ably most suitable for improving the electro de–neuron 
electrical interface109. The manufacturing of these 
materials allows integration with compliant carrier 
substrates and incorporation in gels. 
Conducting polymers offer mixed electronic and 
ionic conductivity, promising improved charge trans-
fer110. Several groups have reported on long-term neural 
interfaces based on conducting polymers, and extending 
the electrochemical stability of the polymers in vivo is an 
active topic of research94,111–113. PEDOT:PSS, which has a 
Young’s modulus on the order of 100 MPa, is softer than 
standard electrode metals. Conducting polymer–hydrogel 
coatings hold significant promise as biointegrated 
interfaces, whereby the conducting polymer efficiently 
carries charges, and the hydrogel modulates the mechan-
ical properties and may also enhance the drug-carrying 
capacity of the coatings109,114. In another interesting 
approach, tissue-engineered electrodes or ‘live’ elec-
trodes, in which neuronal cells are encapsulated in a soft 
conducting hydrogel scaffold, are tailored to provide 
mechanical and biochemical properties that support cell 
growth and efficient electrochemical interfaces109.
Multimodal soft neural implants
Soft neural implants have, for the most part, been 
prepared with technologies initially developed for the 
microelectronic and telecommunication industries. 
In turn, the use of micro- and nanofabrication tech-
niques in the manufacturing of neural implants in 
basic research has enabled the design of bidirectional 
interfaces, capable of distributed and local delivery 
of multiple inputs, such as electricity, light or drugs, 
and simultaneously monitoring the activity from one 
or several neurons. Currently, research implants for 
neuromodulation are primarily used to write into the 
nervous system using light to stimulate the neural tis-
sues with improved specificity115,116, or a combination 
of two stimulation modalities (for example, electricity 
and pharmacology). Microelectrodes for monitoring 
neural activity are also often included in the multi-
modal stimulation interfaces. For example, injectable 
wireless optoelectronic implants embedded in ultrathin 
polyimide films incorporate independently addressa-
ble microscale inorganic light-emitting diodes that 
are multicoloured and co-located optical, thermal and 
electrophysiological sensors and actuators87 (FIG. 3). 
Complemented by a wireless powering platform, 
sophisticated and miniaturized implants have already 
communicated with the brain of freely moving mice, 
delivering light and pharmacology for several weeks117. 
These results demonstrate the good tolerance of the 
host medium and potential for long-term studies, 
which are essential for the development and under-
standing of neurotherapies. This technology has also 
recently been demonstrated in a bioresorbable format, 
enabling a range of acute and short-term applications 
for transient neural monitoring82,83 (FIG. 6a).
All-polymer fibre probes are another emerging 
approach for multimodal implants. These probes com-
bine fibre-optical stimulation, drug delivery and electri-
cal recording in a diameter of less than 300 μm (REF. 95). 
Stable optical neuromodulation and the adjacent electri-
cal recording of single-unit cortical neural activity have 
been demonstrated for up to 2 months post-implantation. 
In addition, controlled fluid infusion through the 
integrated hollow channels along the fibre allows for 
the delivery of not only drugs, but also viral vectors, 
including those used in optogenetics, and cell-selective 
Figure 6 | Functions with compliant neural interfaces. 
a | A 64-channel, bioresorbable, actively multiplexed 
micro-electrocorticography array on the barrel cortex of 
a rat (left panel, visibly activated whiskers are marked in 
red) and estimated relative location of the recording array 
based on evoked potential results (right panel). b | Acute 
recordings of evoked potentials are made from the barrel 
cortex of a rat following stimulation of the whiskers 
(locations 1 and 2). The 8 × 8 electrode array captures the 
temporal characteristics (top panels) of the evoked 
potentials and their spatial distribution (bottom panels) 
on the cortex following two distinct stimulations. The 
colour map indicates the evoked potential size, 
interpolated across the array. c | Multifunctional fibres for 
simultaneous optical, electrical and chemical 
neuromodulation of the brain. The left panel is a 
photograph showing the macroscopic preform and the 
drawn microfibres containing microfluidic channels, 
electrodes and optical waveguides as the inset. The 
panels on the right show that the probes, implanted in the 
prefrontal cortex of Thy1-ChR2-YFP mice, enable 
co-localized optical stimulation (points in the spectra), 
injection of CNQX (synaptic inhibitor) and recordings of 
the corresponding electrophysiological activity at two 
months post-implantation. d | Rats were implanted with a 
spinal electronic dura mater covering the lumbosacral 
segments and received a severe spinal cord injury. The left 
panels are of the lesion reconstruction with photographs 
of the spinal cord injury shown below the schematic 
representation. In the right panels, bipedal locomotion 
under robotic support is recorded without and with 
electrochemical stimulation after three weeks of 
rehabilitation. Stick diagram decompositions of hindlimb 
movements are shown in the top panels. Leg muscle 
activity and hindlimb oscillations are shown below. 
CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; CPE, 
carbon-paste electrode. Parts a and b are from REF. 83, 
Nature Publishing Group. Part c is from REF. 95, Nature 
Publishing Group. Part d is reproduced with permission 
from REF. 20, AAAS.
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neurotoxins to neural tissues95. Consequently, ultra- 
flexible polymer-based fibre probes appear as a prom-
ising biocompatible, multifunctional tool for dynamic 
optogenetic mapping of neural circuits in freely behaving 
animals (FIG. 6b).
Multimodal soft implants also accelerate progress 
in translational neuroprosthetic research. Electronic 
dura mater is a soft multifunctional implant prepared 
with elastomeric materials and designed to reside in the 
intrathecal space of the CNS20 (FIG. 6c). These implants 
have been used to deliver electrical stimulations over 
multiple locations of the spinal cord and to administer 
serotonergic agents that diffuse in the spinal tissue. The 
concurrent and co-localized electrical and chemical stim-
ulations reactivate the spinal circuits below the injury118, 
which was shown to restore locomotion in paralysed rats. 
The embedded microfluidic channel provides highly 
localized delivery of minimally concentrated pharma-
cological agents. Electrical pulses delivered through the 
patterned microelectrode array to the underlying neural 
structures allow the control of the flexion and extension 
of the hindlimbs of the paralysed rats over the course of 
several weeks post-implantation119.
A bright future for soft neurotechnology
Manufacturing soft implants with brain-like materials 
is not yet possible; nevertheless, simple design rules 
(for example, based on thin, flexible materials, elastic 
membranes, miniaturization to cellular and even sub-
cellular dimensions, multiscale 3D formats and co- 
localization of different types of transducers) now drive 
the research community to engineer and test soft neural 
implants with unprecedented biological integration and 
modalities.
Although the path to clinical translation remains 
challenging, the soft neurotechnologies reviewed in this 
article create possibilities for the development of new 
therapeutic treatments. The exciting results acquired 
in academic research, as well as the recent successes 
of companies such as Second Sight or Sapiens, which 
both engineered advanced implantable neuroprosthetic 
systems with a flexible neural interface at the heart of 
the system, have led to public funding (for example, 
the Brain Initiative in the USA) and unleashed private 
investment in start-ups developing implantable neuro-
prosthetic treatments.
Historically, neuroprosthetic treatments have been 
broadly divided into replacement and restoration 
strategies. Replacement primarily refers to the field of 
brain–machine interfaces, whereas restoration mainly 
focuses on neuromodulation therapies. The lack of bio-
integration in the neural tissue of today’s implantable 
brain–machine interfaces impedes their vast dissemina-
tion into medical applications. As a consequence, neu-
rointegrated implants, enabled in part by a more careful 
physical matching of the synthetic–biological interface 
and providing stable recordings of spiking activity for 
extended durations, would herald a new era for brain–
machine interfaces, in which the prospect of restoring 
independent communication and assistive device con-
trol for people with paralysis would become reality. The 
stable delivery of electrical currents to the nervous sys-
tem is considerably less challenging than the long-term 
recording of electrical signals from neural structures. It 
therefore comes as no surprise that neuromodulation 
therapies reached clinical fruition more rapidly than 
brain–machine interface technologies. For example, 
dopamine precursors and deep-brain stimulation of the 
basal ganglia circuitry have become common medical 
practices to alleviate cognitive and motor symptoms 
associated with Parkinson’s disease.
Theoretically, the possibility of directly and precisely 
targeting specific brain120 and spinal cord119 structures 
with neuromodulation therapies can lead to remarkably 
more robust interventions. Soft electrode implants will 
have a pivotal role in enabling this approach. Indeed, 
chronic neuromodulation of targeted neural struc-
tures across and within the brain and spinal cord will 
require customized soft implants that match, or at least 
approach, neural tissue compliance, conform to the 
unique topography of these regions, and are capable of 
spatial and temporal selectivity. Moreover, the possibil-
ity to integrate microfluidic channels to deliver drugs 
locally creates exciting prospects of modulating neural 
excitability and boosting neuroplasticity. Local injections 
induce fewer side effects than systemic administration, 
which allows higher drug concentrations and thus more 
potent effects20. Many clinically approved compounds 
could be used in these applications.
The historical distinction between replacement and 
restoration strategies is becoming vague and ambig-
uous. The marriage of brain–machine interface tech-
nologies with neuromodulation therapies is occurring 
at a fast pace. Bidirectional implanted neuroprosthe-
ses combining recording and stimulating capabilities 
offer a unique opportunity to incorporate neural sig-
nals into closed-loop stimulation algorithms. The user 
then directly triggers and modulates the features of the 
therapy. For example, a quadriplegic person regained 
cortical control over isolated finger movements using 
a brain-controlled stimulation of hand muscles2. This 
approach121 to neuroprosthetic designs is already sup-
ported in various research programs. For example, the 
aim of the ElectRx program is to develop intelligent 
pacemakers that personalize neuromodulation ther-
apies through the closed-loop control of stimulation 
parameters. Next-generation implants with bidirec-
tional and multimodal capabilities will have a central 
role in the success of these programs.
In summary, we are entering the era of personalized 
neuroprosthetics122. Because of the central role of the 
synthetic–biological interface, it is critical that materials 
scientists and engineers effectively design implant mat-
erials and structures that create an adequate biological 
and mechanical response with the soft neural tissue. We 
have gathered the first elements indicating that implant 
softness is essential to long-term use. It is an exciting 
time for materials scientists and engineers to discover 
how to further tailor implantable neuroprostheses and 
endow individuals suffering from traumatic or neuro-
logical disorders with personalized and life-changing 
therapeutic treatments.
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